% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • ajthedrifter ajthedrifter Jan 21, 2012 1:05 PM Flag

    Buying Shares

    The drug makers will be lining up to partner with IMUC when phase 2 data is released. In my opinion, there will probably be a nice premium that will far surpass the costs of the phase 3 trial for ICT-107 and the excess funds can go towards the development of their other pipeline candidates. Current cash position combined with how far along they are with trial puts them in a strong spot to negotiate a lucrative deal.